iifl-logo

News Overview

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Download App
image

The loans on the app will be offered at competitive terms and would result in significant savings for the users.

image

According to a regulatory filing by Zydus Lifesciences, the USFDA approved Paliperidone extended-release tablets.

image

The regulator stated that all participants should refer to the Ministry of Finance's Accessibility Standards.

image

The company produces advanced pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for formulations like tablets, syrups, ointments, etc.

image

Alkem will conduct clinical trials of 'SON-080' in India, with Sonnet's support for global and local regulatory submissions.

image

In a meeting on Thursday, the board approved this fundraising initiative, which will include the issuing of equity shares.

image

During the reporting year, the state-owned firm's total operating income increased by 38% year on year to ₹1,630.38 Crore.

image

The project involves integrated infrastructure development for 20M, including wide roads, flyovers, minor bridges, and electrical works under the NAINA project.

image

NSE updates the list of securities banned in the F&O segment daily, depending on the MWPL thresholds.

image

The company will use net proceeds from the IPO towards working capital requirements and other general corporate purposes as well as unidentified inorganic acquisitions.

Download App
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.